Splice variants of the P2X7 receptor reveal differential agonist dependence and functional coupling with pannexin-1

Xing Jian Xu1, Miyyada Boumechache, Lucy E Robinson

  • 1Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK.

Insights

The P2X7k receptor variant, found in T lymphocytes, mediates NAD sensitivity and enhanced ethidium uptake, unlike the P2X7a variant. This P2X7k receptor

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • P2X7 receptors are ATP-gated cation channels involved in cellular signaling and death.
  • Receptor-mediated membrane permeabilization and differential sensitivity to NAD+ remain poorly understood.
  • Alternative P2X7 receptor variants exist with distinct cellular distributions and functions.

Purpose of the Study:

  • To elucidate the mechanisms underlying differential sensitivity to NAD+ in P2X7 receptor variants.
  • To investigate the role of specific P2X7 receptor variants in cellular responses like ethidium uptake and calcium influx.
  • To explore the relationship between P2X7 receptors, pannexin-1, and caspase activation.

Main Methods:

  • Studied alternative mouse P2X7 receptor variants (P2X7a and P2X7k).
  • Assessed NAD+ sensitivity, ethidium uptake, intracellular Ca2+ rise, and inward currents.
  • Utilized co-expression studies, single nucleotide polymorphism analysis, and in situ proximity assays.

Main Results:

  • The P2X7k variant, expressed in T lymphocytes, mediates NAD+ sensitivity and enhanced ethidium uptake, unlike P2X7a.
  • P2X7k receptor's altered N-terminus and TM1 stabilize its active state, increasing NAD-dependent ADP ribosylation efficacy.
  • P2X7k-mediated uptake is largely independent of pannexin-1, while P2X7aL451 shows some pannexin-1 dependence; signaling occurs downstream of caspases.

Conclusions:

  • P2X7k receptor variant is responsible for NAD+ sensitivity and enhanced ethidium uptake in T lymphocytes.
  • The P2X7k variant exhibits distinct properties compared to P2X7a, including altered channel stability and pannexin-1 independence.
  • P2X7 receptor signaling, particularly via P2X7k, involves pathways downstream of caspase activation and shows close association with pannexin-1.

Related Concept Videos

Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Spare Receptors01:30

Spare Receptors

Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...